{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "34567218", "DateRevised": {"Year": "2021", "Month": "09", "Day": "29"}, "Article": {"ArticleDate": [{"Year": "2021", "Month": "09", "Day": "16"}], "Language": ["eng"], "ELocationID": ["6681540", "10.1155/2021/6681540"], "Journal": {"ISSN": "1741-427X", "JournalIssue": {"Volume": "2021", "PubDate": {"Year": "2021"}}, "Title": "Evidence-based complementary and alternative medicine : eCAM", "ISOAbbreviation": "Evid Based Complement Alternat Med"}, "ArticleTitle": "Bioactive Foods and Medicinal Plants for Cardiovascular Complications of Type II Diabetes: Current Clinical Evidence and Future Perspectives.", "Pagination": {"StartPage": "6681540", "MedlinePgn": "6681540"}, "Abstract": {"AbstractText": ["Cardiovascular diseases (CVDs) are the main cause of mortality in type 2 diabetes mellitus (T2DM); however, not all patients are fully satisfied with the current available treatments. Medicinal plants have been globally investigated regarding their effect in CVD, yet the field is far from getting exhausted. The current paper aims to provide an evidence-based review on the clinically evaluated medicinal plants and their main therapeutic targets for the management of CVD in T2DM. Electronic databases including PubMed, Cochrane, Embase, Scopus, and Web of Science were searched from 2000 until November 2019, and related clinical studies were included. Lipid metabolism, glycemic status, systemic inflammation, blood pressure, endothelial function, oxidative stress, and anthropometric parameters are the key points regulated by medicinal plants in T2DM. Anti-inflammatory and antioxidant properties are the two most important mechanisms since inflammation and oxidative stress are the first steps triggering a domino of molecular pathological pathways leading to T2DM and, subsequently, CVD. Polyphenols with potent antioxidant and anti-inflammatory effects, essential oil-derived compounds with vasorelaxant properties, and fibers with demonstrated effects on obesity are the main categories of phytochemicals beneficial for CVD of T2DM. Some medicinal plants such as garlic (<i>Allium sativum</i>) and milk thistle (<i>Silybum marianum</i>) have strong evidences regarding their beneficial effects; however, others have low level of evidence which reveals the need for further clinical studies with larger sample sizes and longer follow-up periods to confirm the safety and efficacy of medicinal plants for the management of CVD in T2DM."], "CopyrightInformation": "Copyright \u00a9 2021 Roodabeh Bahramsoltani et al."}, "AuthorList": [{"Identifier": ["0000-0001-6942-0546"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Traditional Pharmacy, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "PhytoPharmacology Interest Group (PPIG), Universal Scientific Education and Research Network (USERN), Tehran, Iran."}], "LastName": "Bahramsoltani", "ForeName": "Roodabeh", "Initials": "R"}, {"Identifier": ["0000-0001-7081-6521"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran."}, {"Identifier": [], "Affiliation": "Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran."}], "LastName": "Farzaei", "ForeName": "Mohammad Hosein", "Initials": "MH"}, {"Identifier": ["0000-0002-7269-6129"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Student Research Committee, Faculty of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran."}], "LastName": "Ram", "ForeName": "Mahboobe", "Initials": "M"}, {"Identifier": ["0000-0002-5206-6197"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Evidence-Based Medicine Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Department of Pharmacoeconomics and Pharmaceutical Administration, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Nikfar", "ForeName": "Shekoufeh", "Initials": "S"}, {"Identifier": ["0000-0001-8637-4350"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Traditional Pharmacy, School of Persian Medicine, Tehran University of Medical Sciences, Tehran, Iran."}, {"Identifier": [], "Affiliation": "Evidence-Based Medicine Group, Pharmaceutical Sciences Research Center, Tehran University of Medical Sciences, Tehran, Iran."}], "LastName": "Rahimi", "ForeName": "Roja", "Initials": "R"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Evid Based Complement Alternat Med", "NlmUniqueID": "101215021", "ISSNLinking": "1741-427X"}, "CoiStatement": "Authors declare no conflicts of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Zheng Y., Ley S. H., Hu F. B. Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nature Reviews Endocrinology. 2018;14(2):88\u201398. doi: 10.1038/nrendo.2017.151.", "ArticleIdList": ["10.1038/nrendo.2017.151", "29219149"]}, {"Citation": "Zimmet P. Z., Magliano D. J., Herman W. H., Shaw J. E. Diabetes: a 21st century challenge. The Lancet Diabetes & Endocrinology. 2014;2(1):56\u201364. doi: 10.1016/s2213-8587(13)70112-8.", "ArticleIdList": ["10.1016/s2213-8587(13)70112-8", "24622669"]}, {"Citation": "Wild S., Roglic G., Green A., Sicree R., King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27(5):1047\u20131053. doi: 10.2337/diacare.27.5.1047.", "ArticleIdList": ["10.2337/diacare.27.5.1047", "15111519"]}, {"Citation": "Norhammar A., Mellbin L., Cosentino F. Diabetes: prevalence, prognosis and management of a potent cardiovascular risk factor. European Journal of Preventive Cardiology. 2017;24(3):52\u201360. doi: 10.1177/2047487317709554.", "ArticleIdList": ["10.1177/2047487317709554", "28618910"]}, {"Citation": "Morrish N. J., Wang S. L., Stevens L. K., Fuller J. H., Keen H. Mortality and causes of death in the WHO multinational study of vascular disease in diabetes. Diabetologia. 2001;44(2):S14\u2013S21. doi: 10.1007/pl00002934.", "ArticleIdList": ["10.1007/pl00002934", "11587045"]}, {"Citation": "Kannel W. B., McGee D. L. Diabetes and cardiovascular disease. JAMA. 1979;241(19):2035\u20132038. doi: 10.1001/jama.1979.03290450033020.", "ArticleIdList": ["10.1001/jama.1979.03290450033020", "430798"]}, {"Citation": "Aune D., Feng T., Schlesinger S., Janszky I., Norat T., Riboli E. Diabetes mellitus, blood glucose and the risk of atrial fibrillation: a systematic review and meta-analysis of cohort studies. Journal of Diabetes and Its Complications. 2018;32(5):501\u2013511. doi: 10.1016/j.jdiacomp.2018.02.004.", "ArticleIdList": ["10.1016/j.jdiacomp.2018.02.004", "29653902"]}, {"Citation": "Aune D., Schlesinger S., Norat T., Riboli E. Diabetes mellitus and the risk of sudden cardiac death: a systematic review and meta-analysis of prospective studies. Nutrition, Metabolism, and Cardiovascular Diseases. 2018;28(6):543\u2013556. doi: 10.1016/j.numecd.2018.02.011.", "ArticleIdList": ["10.1016/j.numecd.2018.02.011", "29730085"]}, {"Citation": "Petrie J. R., Guzik T. J., Touyz R. M. Diabetes, hypertension, and cardiovascular disease: clinical insights and vascular mechanisms. Canadian Journal of Cardiology. 2018;34(5):575\u2013584. doi: 10.1016/j.cjca.2017.12.005.", "ArticleIdList": ["10.1016/j.cjca.2017.12.005", "PMC5953551", "29459239"]}, {"Citation": "Klajda M. D., Scott C. G., Rodeheffer R. J., Chen H. H. Diabetes mellitus is associated with increased incidence of CHF independent of hypertension and coronary artery disease: a population based study. Journal of Cardiac Failure. 2018;24(8):p. S70. doi: 10.1016/j.cardfail.2018.07.467.", "ArticleIdList": ["10.1016/j.cardfail.2018.07.467"]}, {"Citation": "Casula M., Mozzanica F., Scotti L., et al. Statin use and risk of new-onset diabetes: a meta-analysis of observational studies. Nutrition, Metabolism, and Cardiovascular Diseases. 2017;27(5):396\u2013406. doi: 10.1016/j.numecd.2017.03.001.", "ArticleIdList": ["10.1016/j.numecd.2017.03.001", "28416099"]}, {"Citation": "Abdul-Ghani M., DeFronzo R. A., Del Prato S., Chilton R., Singh R., Ryder R. E. J. Cardiovascular disease and type 2 diabetes: has the dawn of a new era arrived? Diabetes Care. 2017;40(7):813\u2013820. doi: 10.2337/dc16-2736.", "ArticleIdList": ["10.2337/dc16-2736", "PMC5481984", "28637886"]}, {"Citation": "Pallisgaard J. L., Brooks M. M., Chaitman B. R., Boothroyd D. B., Perez M., Hlatky M. A. Thiazolidinediones and risk of atrial fibrillation among patients with diabetes and coronary disease. The American Journal of Medicine. 2018;131(7):805\u2013812. doi: 10.1016/j.amjmed.2018.02.026.", "ArticleIdList": ["10.1016/j.amjmed.2018.02.026", "PMC7250530", "29581079"]}, {"Citation": "Lecka-Czernik B. Diabetes, bone and glucose-lowering agents: basic biology. Diabetologia. 2017;60(7):1163\u20131169. doi: 10.1007/s00125-017-4269-4.", "ArticleIdList": ["10.1007/s00125-017-4269-4", "PMC5487688", "28434032"]}, {"Citation": "Karimi A., Zargaran A., Borhani-Haghighi A. Avicenna\u2019s description of Willis circle. International Journal of Cardiology. 2013;168(3):p. 3041. doi: 10.1016/j.ijcard.2013.04.132.", "ArticleIdList": ["10.1016/j.ijcard.2013.04.132", "23643428"]}, {"Citation": "Zarshenas M. M., Zargaran A. A review on the Avicenna\u2019s contribution to the field of cardiology. International Journal of Cardiology. 2015;182:237\u2013241. doi: 10.1016/j.ijcard.2014.12.145.", "ArticleIdList": ["10.1016/j.ijcard.2014.12.145", "25577770"]}, {"Citation": "Bahramsoltani R., Ebrahimi F., Farzaei M. H., et al. Dietary polyphenols for atherosclerosis: a comprehensive review and future perspectives. Critical Reviews in Food Science and Nutrition. 2017;59:114\u2013132. doi: 10.1080/10408398.2017.1360244.", "ArticleIdList": ["10.1080/10408398.2017.1360244", "28812379"]}, {"Citation": "Rouhi-Boroujeni H., Heidarian E., Rouhi-Boroujeni H., Deris F., Rafieian-Kopaei M. Medicinal plants with multiple effects on cardiovascular diseases: a systematic review. Current Pharmaceutical Design. 2017;23(7):999\u20131015. doi: 10.2174/1381612822666161021160524.", "ArticleIdList": ["10.2174/1381612822666161021160524", "27774898"]}, {"Citation": "Xu Y.-J., Tappia P. S., Neki N. S., Dhalla N. S. Prevention of diabetes-induced cardiovascular complications upon treatment with antioxidants. Heart Failure Reviews. 2014;19(1):113\u2013121. doi: 10.1007/s10741-013-9379-6.", "ArticleIdList": ["10.1007/s10741-013-9379-6", "23436032"]}, {"Citation": "Jadad A. R., Moore R. A., Carroll D., et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Controlled Clinical Trials. 1996;17(1):1\u201312. doi: 10.1016/0197-2456(95)00134-4.", "ArticleIdList": ["10.1016/0197-2456(95)00134-4", "8721797"]}, {"Citation": "Ebrahimpour-Koujan S., Gargari B. P., Mobasseri M., Valizadeh H., Asghari-Jafarabadi M. Lower glycemic indices and lipid profile among type 2 diabetes mellitus patients who received novel dose of Silybum marianum (L.) Gaertn. (silymarin) extract supplement: a triple-blinded randomized controlled clinical trial. Phytomedicine. 2018;44:39\u201344. doi: 10.1016/j.phymed.2018.03.050.", "ArticleIdList": ["10.1016/j.phymed.2018.03.050", "29895491"]}, {"Citation": "Ebrahimpour Koujan S., Gargari B. P., Mobasseri M., Valizadeh H., Asghari-Jafarabadi M. Effects of Silybum marianum (L.) Gaertn. (silymarin) extract supplementation on antioxidant status and hs-CRP in patients with type 2 diabetes mellitus: a randomized, triple-blind, placebo-controlled clinical trial. Phytomedicine. 2015;22(2):290\u2013296. doi: 10.1016/j.phymed.2014.12.010.", "ArticleIdList": ["10.1016/j.phymed.2014.12.010", "25765835"]}, {"Citation": "Nazni P., Poongodi Vijayakumar T., Alagianambi P., Amirthaveni M. Hypoglycemic and hypolipidemic effect of Cynara scolymus among selected type 2 diabetic individuals. Pakistan Journal of Nutrition. 2006;5(2):147\u2013151. doi: 10.3923/pjn.2006.147.151.", "ArticleIdList": ["10.3923/pjn.2006.147.151"]}, {"Citation": "Fallah Huseini H., Kianbakht S., Heshmat R. Cynara scolymus L. in treatment of hypercholesterolemic type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Journal of Medicinal Plants. 2012;1(41):85\u201365."}, {"Citation": "Ashraf R., Aamir K., Shaikh A. R., Ahmed T. Effects of garlic on dyslipidemia in patients with type 2 diabetes mellitus. Journal of Ayub Medical College, Abbottabad: JAMC. 2005;17(3):60\u201364.", "ArticleIdList": ["16320801"]}, {"Citation": "Ashraf R., Khan R. A., Ashraf I. Garlic (Allium sativum) supplementation with standard antidiabetic agent provides better diabetic control in type 2 diabetes patients. Pakistan Journal of Pharmaceutical Sciences. 2011;24(4):565\u2013570.", "ArticleIdList": ["21959822"]}, {"Citation": "Atkin M., Laight D., Cummings M. H. The effects of garlic extract upon endothelial function, vascular inflammation, oxidative stress and insulin resistance in adults with type 2 diabetes at high cardiovascular risk. A pilot double blind randomized placebo controlled trial. Journal of Diabetes and Its Complications. 2016;30(4):723\u2013727. doi: 10.1016/j.jdiacomp.2016.01.003.", "ArticleIdList": ["10.1016/j.jdiacomp.2016.01.003", "26954484"]}, {"Citation": "Mahluji S., Attari V. E., Mobasseri M., Payahoo L., Ostadrahimi A., Golzari S. E. Effects of ginger (Zingiber officinale) on plasma glucose level, HbA1c and insulin sensitivity in type 2 diabetic patients. International Journal of Food Sciences & Nutrition. 2013;64(6):682\u2013686. doi: 10.3109/09637486.2013.775223.", "ArticleIdList": ["10.3109/09637486.2013.775223", "23496212"]}, {"Citation": "Arablou T., Aryaeian N., Valizadeh M., Sharifi F., Hosseini A., Djalali M. The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus. International Journal of Food Sciences & Nutrition. 2014;65(4):515\u2013520. doi: 10.3109/09637486.2014.880671.", "ArticleIdList": ["10.3109/09637486.2014.880671", "24490949"]}, {"Citation": "Shidfar F., Rajab A., Rahideh T., Khandouzi N., Hosseini S., Shidfar S. The effect of ginger (Zingiber officinale) on glycemic markers in patients with type 2 diabetes. Journal of Complementary & Integrative Medicine. 2015;12(2):165\u2013170. doi: 10.1515/jcim-2014-0021.", "ArticleIdList": ["10.1515/jcim-2014-0021", "25719344"]}, {"Citation": "Hosseini S., Alipour M., Zakerkish M., Haghighizadeh M. H. Effects of standardized extract of ginseng (G115) on biomarkers of systemic low-grade inflammation in patients with type 2 diabetes: a double-blind clinical trial. Iranian Journal of Endocrinology and Metabolism. 2014;16(3):175\u2013182."}, {"Citation": "Namazi N., Esfanjani A. T., Heshmati J., Bahrami A. The effect of hydro alcoholic Nettle (Urtica dioica) extracts on insulin sensitivity and some inflammatory indicators in patients with type 2 diabetes: a randomized double-blind control trial. Pakistan Journal of Biological Sciences. 2011;14(15):775\u2013779. doi: 10.3923/pjbs.2011.775.779.", "ArticleIdList": ["10.3923/pjbs.2011.775.779", "22303583"]}, {"Citation": "Behzadi A. A., Kalalian-Moghaddam H., Ahmadi A. H. Effects of Urtica dioica supplementation on blood lipids, hepatic enzymes and nitric oxide levels in type 2 diabetic patients: a double blind, randomized clinical trial. Avicenna Journal of Phytomedicine. 2016;6(6):p. 686.", "ArticleIdList": ["PMC5206926", "28078249"]}, {"Citation": "Sohrab G., Ebrahimof S., Sotoudeh G., et al. Effects of pomegranate juice consumption on oxidative stress in patients with type 2 diabetes: a single-blind, randomized clinical trial. International Journal of Food Sciences & Nutrition. 2017;68(2):249\u2013255. doi: 10.1080/09637486.2016.1229760.", "ArticleIdList": ["10.1080/09637486.2016.1229760", "27633135"]}, {"Citation": "Shidfar F., Heydari I., Hajimiresmaiel S. J., Hosseini S., Shidfar S., Amiri F. The effects of cranberry juice on serum glucose, apoB, apoA-I, Lp(a), and paraoxonase-1 activity in type 2 diabetic male patients. Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences. 2012;17(4):355\u2013360.", "ArticleIdList": ["PMC3526129", "23267397"]}, {"Citation": "Kar P., Laight D., Rooprai H. K., Shaw K. M., Cummings M. Effects of grape seed extract in type 2 diabetic subjects at high cardiovascular risk: a double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity. Diabetic Medicine. 2009;26(5):526\u2013531. doi: 10.1111/j.1464-5491.2009.02727.x.", "ArticleIdList": ["10.1111/j.1464-5491.2009.02727.x", "19646193"]}, {"Citation": "Mucalo I., Jovanovski E., Raheli\u0107 D., Bo\u017eikov V., Romi\u0107 \u017d., Vuksan V. Effect of American ginseng (Panax quinquefolius L.) on arterial stiffness in subjects with type-2 diabetes and concomitant hypertension. Journal of Ethnopharmacology. 2013;150(1):148\u2013153. doi: 10.1016/j.jep.2013.08.015.", "ArticleIdList": ["10.1016/j.jep.2013.08.015", "23973636"]}, {"Citation": "Lazavi F., Mirmiran P., Sohrab G., Nikpayam O., Angoorani P., Hedayati M. The barberry juice effects on metabolic factors and oxidative stress in patients with type 2 diabetes: a randomized clinical trial. Complementary Therapies in Clinical Practice. 2018;31:170\u2013174. doi: 10.1016/j.ctcp.2018.01.009.", "ArticleIdList": ["10.1016/j.ctcp.2018.01.009", "29705451"]}, {"Citation": "Shidfar F., Ebrahimi S. S., Hosseini S., Heydari I., Shidfar S., Hajhassani G. The effects of Berberis vulgaris fruit extract on serum lipoproteins, apoB, apoA-I, homocysteine, glycemic control and total antioxidant capacity in type 2 diabetic patients. Iranian Journal of Pharmaceutical Research. 2012;11(2):643\u2013652.", "ArticleIdList": ["PMC3832145", "24250489"]}, {"Citation": "Sharma R. K., Sharma B., Jindal M., et al. Evaluation of hypolipidemic effect of stem part of Berberis aristata in type 2 diabetes mellitus patients as add on therapy. National Journal of Physiology, Pharmacy and Pharmacology. 2017;7(11):1A\u201311A. doi: 10.5455/njppp.2017.7.0517510062017.", "ArticleIdList": ["10.5455/njppp.2017.7.0517510062017"]}, {"Citation": "Qian S., Wang S., Fan P., Huo D., Dai L., Qian Q. Effect of Salvia miltiorrhiza hydrophilic extract on the endothelial biomarkers in diabetic patients with chronic artery disease. Phytotherapy Research. 2012;26(10):1575\u20131578. doi: 10.1002/ptr.4611.", "ArticleIdList": ["10.1002/ptr.4611", "22318996"]}, {"Citation": "Li X.-s., Zheng W.-y., Lou S.-x., Lu X.-w., Ye S.-h. Effect of Ginkgo leaf extract on vascular endothelial function in patients with early stage diabetic nephropathy. Chinese Journal of Integrative Medicine. 2009;15(1):26\u201329. doi: 10.1007/s11655-009-0026-8.", "ArticleIdList": ["10.1007/s11655-009-0026-8", "19271166"]}, {"Citation": "Dall\u2019Alba V., Silva F. M., Antonio J. P., et al. Improvement of the metabolic syndrome profile by soluble fibre-guar gum-in patients with type 2 diabetes: a randomised clinical trial. British Journal of Nutrition. 2013;110(9):1601\u20131610. doi: 10.1017/s0007114513001025.", "ArticleIdList": ["10.1017/s0007114513001025", "23551992"]}, {"Citation": "Ma X., Gu J., Zhang Z., et al. Effects of Avena nuda L. on metabolic control and cardiovascular disease risk among Chinese patients with diabetes and meeting metabolic syndrome criteria: secondary analysis of a randomized clinical trial. European Journal of Clinical Nutrition. 2013;67(12):1291\u20131297. doi: 10.1038/ejcn.2013.201.", "ArticleIdList": ["10.1038/ejcn.2013.201", "24129363"]}, {"Citation": "Taghavi M., Farid Hoseini R., Rafat Panah H., Sharifian Razavi M., Watson R. Effect of feijoa supplementation in patients with type 2 diabetes. Iranian Journal of Endocrinology and Metabolism. 2012;14(3):222\u2013225."}, {"Citation": "Sobenin I. A., Nedosugova L. V., Filatova L. V., Balabolkin M. I., Gorchakova T. V., Orekhov A. N. Metabolic effects of time-released garlic powder tablets in type 2 diabetes mellitus: the results of double-blinded placebo-controlled study. Acta Diabetologica. 2008;45(1):1\u20136. doi: 10.1007/s00592-007-0011-x.", "ArticleIdList": ["10.1007/s00592-007-0011-x", "17823766"]}, {"Citation": "Huseini H. F., Kianbakht S., Hajiaghaee R., Dabaghian F. H. Anti-hyperglycemic and anti-hypercholesterolemic effects of Aloe vera leaf gel in hyperlipidemic type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Planta Medica. 2012;78(4):311\u2013316. doi: 10.1055/s-0031-1280474.", "ArticleIdList": ["10.1055/s-0031-1280474", "22198821"]}, {"Citation": "Zarrintan A., Mobasseri M., Zarrintan A., Ostadrahimi A. Effects of aloe vera supplements on blood glucose level and lipid profile markers in type 2 diabetic patients\u2014a randomized clinical trial. Pharmaceutical Sciences. 2015;21(2):65\u201371. doi: 10.15171/ps.2015.19.", "ArticleIdList": ["10.15171/ps.2015.19"]}, {"Citation": "Azadmehr A., Ziaee A., Ghanei L., et al. A randomized clinical trial study: anti-oxidant, anti-hyperglycemic and anti-hyperlipidemic effects of olibanum gum in type 2 diabetic patients. Iranian Journal of Pharmaceutical Research. 2014;13(3):1003\u20131009.", "ArticleIdList": ["PMC4177622", "25276202"]}, {"Citation": "Jenkins D. J. A., Kendall C. W. C., Vuksan V., et al. Effect of lowering the glycemic load with canola oil on glycemic control and cardiovascular risk factors: a randomized controlled trial. Diabetes Care. 2014;37(7):1806\u20131814. doi: 10.2337/dc13-2990.", "ArticleIdList": ["10.2337/dc13-2990", "24929428"]}, {"Citation": "Bahadoran Z., Mirmiran P., Hosseinpanah F., Rajab A., Asghari G., Azizi F. Broccoli sprouts powder could improve serum triglyceride and oxidized LDL/LDL-cholesterol ratio in type 2 diabetic patients: a randomized double-blind placebo-controlled clinical trial. Diabetes Research and Clinical Practice. 2012;96(3):348\u2013354. doi: 10.1016/j.diabres.2012.01.009.", "ArticleIdList": ["10.1016/j.diabres.2012.01.009", "22325157"]}, {"Citation": "Somanah J., Aruoma O. I., Gunness T. K., et al. Effects of a short term supplementation of a fermented papaya preparation on biomarkers of diabetes mellitus in a randomized Mauritian population. Preventive Medicine. 2012;54:S90\u2013S97. doi: 10.1016/j.ypmed.2012.01.014.", "ArticleIdList": ["10.1016/j.ypmed.2012.01.014", "22330753"]}, {"Citation": "Khan A., Safdar M., Ali Khan M. M., Khattak K. N., Anderson R. A. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care. 2003;26(12):3215\u20133218. doi: 10.2337/diacare.26.12.3215.", "ArticleIdList": ["10.2337/diacare.26.12.3215", "14633804"]}, {"Citation": "Wainstein J., Stern N., Heller S., Boaz M. Dietary cinnamon supplementation and changes in systolic blood pressure in subjects with type 2 diabetes. Journal of Medicinal Food. 2011;14(12):1505\u20131510. doi: 10.1089/jmf.2010.0300.", "ArticleIdList": ["10.1089/jmf.2010.0300", "21861719"]}, {"Citation": "Talaei B., Amouzegar A., Sahranavard S., Hedayati M., Mirmiran P., Azizi F. Effects of cinnamon consumption on glycemic indicators, advanced glycation end products, and antioxidant status in type 2 diabetic patients. Nutrients. 2017;9 doi: 10.3390/nu9090991.", "ArticleIdList": ["10.3390/nu9090991", "PMC5622751", "28885566"]}, {"Citation": "Dalli E., Colomer E., Tormos M. C., et al. Crataegus laevigata decreases neutrophil elastase and has hypolipidemic effect: a randomized, double-blind, placebo-controlled trial. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology. 2011;18(8-9):769\u2013775. doi: 10.1016/j.phymed.2010.11.011.", "ArticleIdList": ["10.1016/j.phymed.2010.11.011", "21242072"]}, {"Citation": "Walker A. F., Marakis G., Simpson E., et al. Hypotensive effects of hawthorn for patients with diabetes taking prescription drugs: a randomised controlled trial. British Journal of General Practice. 2006;56(527):437\u2013443.", "ArticleIdList": ["PMC1839018", "16762125"]}, {"Citation": "Moravej Aleali A., Amani R., Shahbazian H., Namjooyan F., Latifi S. M., Cheraghian B. The effect of hydroalcoholic saffron (Crocus sativus L.) extract on fasting plasma glucose, HbA1c, lipid profile, liver, and renal function tests in patients with type 2 diabetes mellitus: a randomized double\u2010blind clinical trial. Phytotherapy Research. 2019;33(6):1648\u20131657. doi: 10.1002/ptr.6351.", "ArticleIdList": ["10.1002/ptr.6351", "30942510"]}, {"Citation": "Bayat A., Azizi-Soleiman F., Heidari-Beni M., et al. Effect of Cucurbita ficifolia and probiotic yogurt consumption on blood glucose, lipid profile, and inflammatory marker in type 2 diabetes. International Journal of Preventive Medicine. 2016;7:p. 30. doi: 10.4103/2008-7802.175455.", "ArticleIdList": ["10.4103/2008-7802.175455", "PMC4763470", "26955460"]}, {"Citation": "Chuengsamarn S., Rattanamongkolgul S., Phonrat B., Tungtrongchitr R., Jirawatnotai S. Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial. The Journal of Nutritional Biochemistry. 2014;25(2):144\u2013150. doi: 10.1016/j.jnutbio.2013.09.013.", "ArticleIdList": ["10.1016/j.jnutbio.2013.09.013", "24445038"]}, {"Citation": "Srinivasan A., Selvarajan S., Kamalanathan S., Kadhiravan T., Prasanna Lakshmi N. C., Adithan S. Effect of Curcuma longa on vascular function in native Tamilians with type 2 diabetes mellitus: a randomized, double\u2010blind, parallel arm, placebo\u2010controlled trial. Phytotherapy Research. 2019;33(7):1898\u20131911. doi: 10.1002/ptr.6381.", "ArticleIdList": ["10.1002/ptr.6381", "31155769"]}, {"Citation": "Adab Z., Eghtesadi S., Vafa M. R., et al. Effect of turmeric on glycemic status, lipid profile, hs\u2010CRP, and total antioxidant capacity in hyperlipidemic type 2 diabetes mellitus patients. Phytotherapy Research. 2019;33(4):1173\u20131181. doi: 10.1002/ptr.6312.", "ArticleIdList": ["10.1002/ptr.6312", "30859660"]}, {"Citation": "Kuate D., Etoundi B. C., Ngondi J. L., Oben J. E. Effects of Dichrostachys glomerata spice on cardiovascular diseases risk factors in normoglycemic and type 2 diabetic obese volunteers. Food Research International. 2011;44(5):1197\u20131202. doi: 10.1016/j.foodres.2010.09.037.", "ArticleIdList": ["10.1016/j.foodres.2010.09.037"]}, {"Citation": "Moazen S., Amani R., Homayouni Rad A., Shahbazian H., Ahmadi K., Taha Jalali M. Effects of freeze-dried strawberry supplementation on metabolic biomarkers of atherosclerosis in subjects with type 2 diabetes: a randomized double-blind controlled trial. Annals of Nutrition and Metabolism. 2013;63(3):256\u2013264. doi: 10.1159/000356053.", "ArticleIdList": ["10.1159/000356053", "24334868"]}, {"Citation": "Kusunoki M., Sato D., Tsutsumi K., Tsutsui H., Nakamura T., Oshida Y. Black soybean extract improves lipid profiles in fenofibrate-treated type 2 diabetics with postprandial hyperlipidemia. Journal of Medicinal Food. 2015;18(6):615\u2013618. doi: 10.1089/jmf.2014.3234.", "ArticleIdList": ["10.1089/jmf.2014.3234", "25651043"]}, {"Citation": "Sedaghat A., Shahbazian H., Rezazadeh A., et al. The effect of soy nut on serum total antioxidant, endothelial function and cardiovascular risk factors in patients with type 2 diabetes. Diabetes & Metabolic Syndrome: Clinical Research Reviews. 2019;13(2):1387\u20131391. doi: 10.1016/j.dsx.2019.01.057.", "ArticleIdList": ["10.1016/j.dsx.2019.01.057", "31336497"]}, {"Citation": "Bandara T., Rokeya B., Khan S., et al. Effects of Gymnema lactiferum leaves on glycemic and lipidemic status in type 2 diabetes subjects. Bangladesh Journal of Pharmacology. 2009;4:92\u201395."}, {"Citation": "Ma Y., Njike V. Y., Millet J., et al. Effects of walnut consumption on endothelial function in type 2 diabetic subjects: a randomized controlled crossover trial. Diabetes Care. 2010;33(2):227\u2013232. doi: 10.2337/dc09-1156.", "ArticleIdList": ["10.2337/dc09-1156", "PMC2809254", "19880586"]}, {"Citation": "Hosseini S., Jamshidi L., Mehrzadi S., et al. Effects of Juglans regia L. leaf extract on hyperglycemia and lipid profiles in type two diabetic patients: a randomized double-blind, placebo-controlled clinical trial. Journal of Ethnopharmacology. 2014;152(3):451\u2013456. doi: 10.1016/j.jep.2014.01.012.", "ArticleIdList": ["10.1016/j.jep.2014.01.012", "24462785"]}, {"Citation": "Rabiei K., Ebrahimzadeh M. A., Saeedi M., Bahar A., Akha O., Kashi Z. Effects of a hydroalcoholic extract of Juglans regia (walnut) leaves on blood glucose and major cardiovascular risk factors in type 2 diabetic patients: a double-blind, placebo-controlled clinical trial. BMC Complementary and Alternative Medicine. 2018;18(1):p. 206. doi: 10.1186/s12906-018-2268-8.", "ArticleIdList": ["10.1186/s12906-018-2268-8", "PMC6031195", "29973195"]}, {"Citation": "Aljamal A. Effects of bay leaves on the patients with diabetes mellitus. Research Journal of Medicinal Plant. 2011;5(4):471\u2013476. doi: 10.3923/rjmp.2011.471.476.", "ArticleIdList": ["10.3923/rjmp.2011.471.476"]}, {"Citation": "Thakur G., Mitra A., Pal K., Rousseau D. Effect of flaxseed gum on reduction of blood glucose and cholesterol in type 2 diabetic patients. International Journal of Food Sciences & Nutrition. 2009;60(6):126\u2013136. doi: 10.1080/09637480903022735.", "ArticleIdList": ["10.1080/09637480903022735", "19548163"]}, {"Citation": "Upritchard J. E., Sutherland W. H., Mann J. I. Effect of supplementation with tomato juice, vitamin E, and vitamin C on LDL oxidation and products of inflammatory activity in type 2 diabetes. Diabetes Care. 2000;23(6):733\u2013738. doi: 10.2337/diacare.23.6.733.", "ArticleIdList": ["10.2337/diacare.23.6.733", "10840987"]}, {"Citation": "Asadi A., Shidfar F., Safari M., et al. Safety and efficacy of Melissa officinalis (lemon balm) on ApoA-I, Apo B, lipid ratio and ICAM-1 in type 2 diabetes patients: a randomized, double-blinded clinical trial. Complementary Therapies in Medicine. 2018;40:83\u201388. doi: 10.1016/j.ctim.2018.07.015.", "ArticleIdList": ["10.1016/j.ctim.2018.07.015", "30219475"]}, {"Citation": "Riche D. M., Riche K. D., East H. E., Barrett E. K., May W. L. Impact of mulberry leaf extract on type 2 diabetes (Mul-DM): a randomized, placebo-controlled pilot study. Complementary Therapies in Medicine. 2017;32:105\u2013108. doi: 10.1016/j.ctim.2017.04.006.", "ArticleIdList": ["10.1016/j.ctim.2017.04.006", "28619294"]}, {"Citation": "Vuksan V., Xu Z. Z., Jovanovski E., et al. Efficacy and safety of American ginseng (Panax quinquefolius L.) extract on glycemic control and cardiovascular risk factors in individuals with type 2 diabetes: a double-blind, randomized, cross-over clinical trial. European Journal of Nutrition. 2018;58(3):1237\u20131245. doi: 10.1007/s00394-018-1642-0.", "ArticleIdList": ["10.1007/s00394-018-1642-0", "29478187"]}, {"Citation": "Raju I. N., Reddy K. K., Kumari C. K., et al. Efficacy of purple passion fruit peel extract in lowering cardiovascular risk factors in type 2 diabetic subjects. Journal of Evidence-Based Complementary & Alternative Medicine. 2013;18(3):183\u2013190. doi: 10.1177/2156587213475627.", "ArticleIdList": ["10.1177/2156587213475627"]}, {"Citation": "Usharani P., Fatima N., Muralidhar N. Effects of Phyllanthus emblica extract on endothelial dysfunction and biomarkers of oxidative stress in patients with type 2 diabetes mellitus: a randomized, double-blind, controlled study. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2013;6:275\u2013284. doi: 10.2147/DMSO.S46341.", "ArticleIdList": ["10.2147/DMSO.S46341", "PMC3735284", "23935377"]}, {"Citation": "Zibadi S., Rohdewald P. J., Park D., Watson R. R. Reduction of cardiovascular risk factors in subjects with type 2 diabetes by pycnogenol supplementation. Nutrition Research. 2008;28(5):315\u2013320. doi: 10.1016/j.nutres.2008.03.003.", "ArticleIdList": ["10.1016/j.nutres.2008.03.003", "19083426"]}, {"Citation": "Ziai S., Larijani B., Fakhrzadeh H., et al. Study of Psyllium (Plantago ovata L.) effects on diabetes and lipidemia in the Iranian type II diabetic patients. Journal of Medicinal Plants. 2004;4(12):33\u201342."}, {"Citation": "Esmaillzadeh A., Zakizadeh E., Faghihimani E., Gohari M., Jazayeri S. The effect of purslane seeds on glycemic status and lipid profiles of persons with type 2 diabetes: a randomized controlled cross-over clinical trial. Journal of Research in Medical Sciences: The Official Journal of Isfahan University of Medical Sciences. 2015;20(1):47\u201353.", "ArticleIdList": ["PMC4354065", "25767522"]}, {"Citation": "Wainstein J., Landau Z., Dayan Y. B., et al. Purslane extract and glucose homeostasis in adults with type 2 diabetes: a double-blind, placebo-controlled clinical trial of efficacy and safety. Journal of Medicinal Food. 2016;19(2):133\u2013140. doi: 10.1089/jmf.2015.0090.", "ArticleIdList": ["10.1089/jmf.2015.0090", "26854844"]}, {"Citation": "Liu J.-F., Liu Y.-H., Chen C.-M., Chang W.-H., Chen C.-Y. O. The effect of almonds on inflammation and oxidative stress in Chinese patients with type 2 diabetes mellitus: a randomized crossover controlled feeding trial. European Journal of Nutrition. 2013;52(3):927\u2013935. doi: 10.1007/s00394-012-0400-y.", "ArticleIdList": ["10.1007/s00394-012-0400-y", "22722891"]}, {"Citation": "Li S.-C., Liu Y.-H., Liu J.-F., Chang W.-H., Chen C.-M., Chen C.-Y. O. Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus. Metabolism. 2011;60(4):474\u2013479. doi: 10.1016/j.metabol.2010.04.009.", "ArticleIdList": ["10.1016/j.metabol.2010.04.009", "20580779"]}, {"Citation": "Fallah Huseini H., Heshmat R., Mohseni F., et al. The efficacy of Rheum ribes L. stalk extract on lipid profile in hypercholesterolemic type II diabetic patients: a randomized, double-blind, placebo-controlled, clinical trial. Journal of Medicinal Plants. 2008;3(27):92\u201397."}, {"Citation": "Kianbakht S., Dabaghian F. H. Improved glycemic control and lipid profile in hyperlipidemic type 2 diabetic patients consuming Salvia officinalis L. leaf extract: a randomized placebo. Controlled clinical trial. Complementary Therapies in Medicine. 2013;21(5):441\u2013446. doi: 10.1016/j.ctim.2013.07.004.", "ArticleIdList": ["10.1016/j.ctim.2013.07.004", "24050577"]}, {"Citation": "Vosough-Ghanbari S., Rahimi R., Kharabaf S., et al. Effects of Satureja khuzestanica on serum glucose, lipids and markers of oxidative stress in patients with type 2 diabetes mellitus: a double-blind randomized controlled trial. Evidence-Based Complementary and Alternative Medicine. 2010;7(4):465\u2013470. doi: 10.1093/ecam/nen018.", "ArticleIdList": ["10.1093/ecam/nen018", "PMC2892343", "18955324"]}, {"Citation": "Mirmiran P., Bahadoran Z., Golzarand M., Rajab A., Azizi F. Ardeh (Sesamum indicum) could improve serum triglycerides and atherogenic lipid parameters in type 2 diabetic patients: a randomized clinical trial. Archives of Iranian Medicine. 2013;16(11):651\u2013656. doi: 10.0131611/AIM.008.", "ArticleIdList": ["10.0131611/AIM.008", "24206407"]}, {"Citation": "Huseini H. F., Larijani B., Fakhrzaeh H., et al. The clinical trial of Silybum marianum seed extract (silymarin) on type II diabetic patients with hyperlipidemia. Journal of Diabetes and Metabolic Disorders. 2004;3:p. 78."}, {"Citation": "Taleb A., Ghanadi F., Changizi Ashtiani S., et al. The effect of aqueous extract thymus Kotschyanus boiss. et hohen on glycemic control and dyslipidemia associated with type II diabetes: a randomized controlled trial. Iranian Journal of Endocrinology and Metabolism. 2017;19(4):234\u2013243."}, {"Citation": "Lee I. T., Chan Y. C., Lin C. W., Lee W. J., Sheu W. H.-H. Effect of cranberry extracts on lipid profiles in subjects with type 2 diabetes. Diabetic Medicine. 2008;25(12):1473\u20131477. doi: 10.1111/j.1464-5491.2008.02588.x.", "ArticleIdList": ["10.1111/j.1464-5491.2008.02588.x", "19046248"]}, {"Citation": "Abedini S., Gargari B. P., Babayi H., Asgarzadeh A. A., Pourabdollahi P. Effect of supplementation with grape seed extract (Vitis vinifera) on serum lipid profiles in patient with type 2 diabetes. Iranian Journal of Endocrinology and Metabolism. 2013;15(1):59\u201366."}, {"Citation": "Dongerkery S. P., Schroeder P. R., Shomali M. E. Insulin and its cardiovascular effects: what is the current evidence? Current Diabetes Reports. 2017;17(12):p. 120. doi: 10.1007/s11892-017-0955-3.", "ArticleIdList": ["10.1007/s11892-017-0955-3", "29058131"]}, {"Citation": "Luo B., Soesanto Y., McClain D. A. Protein modification by O-linked GlcNAc reduces angiogenesis by inhibiting Akt activity in endothelial cells. Arteriosclerosis, Thrombosis, and Vascular Biology. 2008;28(4):651\u2013657. doi: 10.1161/atvbaha.107.159533.", "ArticleIdList": ["10.1161/atvbaha.107.159533", "PMC2734484", "18174452"]}, {"Citation": "Katakami N. Mechanism of development of atherosclerosis and cardiovascular disease in diabetes mellitus. Journal of Atherosclerosis and Thrombosis. 2018;25(1):27\u201339. doi: 10.5551/jat.rv17014.", "ArticleIdList": ["10.5551/jat.rv17014", "PMC5770221", "28966336"]}, {"Citation": "Bahmani M., Shirzad H., Rafieian S., Rafieian-Kopaei M. Silybum marianum: beyond hepatoprotection. Journal of Evidence-Based Complementary & Alternative Medicine. 2015;20(4):292\u2013301. doi: 10.1177/2156587215571116.", "ArticleIdList": ["10.1177/2156587215571116", "25686616"]}, {"Citation": "Taleb A., Ahmad K. A., Ihsan A. U., et al. Antioxidant effects and mechanism of silymarin in oxidative stress induced cardiovascular diseases. Biomedicine & Pharmacotherapy. 2018;102:689\u2013698. doi: 10.1016/j.biopha.2018.03.140.", "ArticleIdList": ["10.1016/j.biopha.2018.03.140", "29604588"]}, {"Citation": "Taskinen M.-R., Bor\u00e9n J. New insights into the pathophysiology of dyslipidemia in type 2 diabetes. Atherosclerosis. 2015;239(2):483\u2013495. doi: 10.1016/j.atherosclerosis.2015.01.039.", "ArticleIdList": ["10.1016/j.atherosclerosis.2015.01.039", "25706066"]}, {"Citation": "Hermans M. P., Valensi P. Elevated triglycerides and low high-density lipoprotein cholesterol level as marker of very high risk in type 2 diabetes. Current Opinion in Endocrinology Diabetes and Obesity. 2018;25(2):118\u2013129. doi: 10.1097/med.0000000000000398.", "ArticleIdList": ["10.1097/med.0000000000000398", "29493554"]}, {"Citation": "Nakano T., Nakajima K., Niimi M., et al. Detection of apolipoproteins B-48 and B-100 carrying particles in lipoprotein fractions extracted from human aortic atherosclerotic plaques in sudden cardiac death cases. Clinica chimica acta; international journal of clinical chemistry. 2008;390(1-2):38\u201343. doi: 10.1016/j.cca.2007.12.012.", "ArticleIdList": ["10.1016/j.cca.2007.12.012", "18206113"]}, {"Citation": "Ray K. K., Seshasai S. R. K., Wijesuriya S., et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. The Lancet. 2009;373(9677):1765\u20131772. doi: 10.1016/s0140-6736(09)60697-8.", "ArticleIdList": ["10.1016/s0140-6736(09)60697-8", "19465231"]}, {"Citation": "Abbasi A., Corpeleijn E., Gansevoort R. T., et al. Role of HDL cholesterol and estimates of HDL particle composition in future development of type 2 diabetes in the general population: the PREVEND study. Journal of Clinical Endocrinology & Metabolism. 2013;98(8):E1352\u2013E1359. doi: 10.1210/jc.2013-1680.", "ArticleIdList": ["10.1210/jc.2013-1680", "23690306"]}, {"Citation": "Schofield J. D., Liu Y., Rao-Balakrishna P., Malik R. A., Soran H. Diabetes dyslipidemia. Diabetes Therapy. 2016;7(2):203\u2013219. doi: 10.1007/s13300-016-0167-x.", "ArticleIdList": ["10.1007/s13300-016-0167-x", "PMC4900977", "27056202"]}, {"Citation": "Verg\u00e8s B. Pathophysiology of diabetic dyslipidaemia: where are we? Diabetologia. 2015;58(5):886\u2013899. doi: 10.1007/s00125-015-3525-8.", "ArticleIdList": ["10.1007/s00125-015-3525-8", "PMC4392164", "25725623"]}, {"Citation": "Li X., Ni J., Tang Y., et al. Allicin inhibits mouse colorectal tumorigenesis through suppressing the activation of STAT3 signaling pathway. Natural Product Research. 2018;33:2722\u20132725. doi: 10.1080/14786419.2018.1465425.", "ArticleIdList": ["10.1080/14786419.2018.1465425", "29683343"]}, {"Citation": "Louis X. L., Murphy R., Thandapilly S. J., Yu L., Netticadan T. Garlic extracts prevent oxidative stress, hypertrophy and apoptosis in cardiomyocytes: a role for nitric oxide and hydrogen sulfide. BMC Complementary and Alternative Medicine. 2012;12(1):p. 140. doi: 10.1186/1472-6882-12-140.", "ArticleIdList": ["10.1186/1472-6882-12-140", "PMC3519616", "22931510"]}, {"Citation": "Shouk R., Abdou A., Shetty K., Sarkar D., Eid A. H. Mechanisms underlying the antihypertensive effects of garlic bioactives. Nutrition Research. 2014;34(2):106\u2013115. doi: 10.1016/j.nutres.2013.12.005.", "ArticleIdList": ["10.1016/j.nutres.2013.12.005", "24461311"]}, {"Citation": "Kumar R., Chhatwal S., Arora S., et al. Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase-lowering effects of garlic in patients with type 2 diabetes mellitus with obesity. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2013;6:49\u201356. doi: 10.2147/dmso.s38888.", "ArticleIdList": ["10.2147/dmso.s38888", "PMC3554227", "23378779"]}, {"Citation": "Alali F. Q., El-Elimat T., Khalid L., Hudaib R., Al-Shehabi T. S., Eid A. H. Garlic for cardiovascular disease: prevention or treatment? Current Pharmaceutical Design. 2017;23(7):1028\u20131041. doi: 10.2174/1381612822666161010124530.", "ArticleIdList": ["10.2174/1381612822666161010124530", "27748188"]}, {"Citation": "Nicoll R., Henein M. Y. Ginger (Zingiber officinale Roscoe): a hot remedy for cardiovascular disease? International Journal of Cardiology. 2009;131(3):408\u2013409. doi: 10.1016/j.ijcard.2007.07.107.", "ArticleIdList": ["10.1016/j.ijcard.2007.07.107", "18037515"]}, {"Citation": "Pradhan A. D., Manson J. E., Rifai N., Buring J. E., Ridker P. M. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA. 2001;286(3):327\u2013334. doi: 10.1001/jama.286.3.327.", "ArticleIdList": ["10.1001/jama.286.3.327", "11466099"]}, {"Citation": "Donath M. Y., Shoelson S. E. Type 2 diabetes as an inflammatory disease. Nature Reviews Immunology. 2011;11(2):98\u2013107. doi: 10.1038/nri2925.", "ArticleIdList": ["10.1038/nri2925", "21233852"]}, {"Citation": "Calle M. C., Fernandez M. L. Inflammation and type 2 diabetes. Diabetes & Metabolism. 2012;38(3):183\u2013191. doi: 10.1016/j.diabet.2011.11.006.", "ArticleIdList": ["10.1016/j.diabet.2011.11.006", "22252015"]}, {"Citation": "Ridker P. M., Danielson E., Fonseca F. A. H., et al. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. New England Journal of Medicine. 2008;359(21):2195\u20132207. doi: 10.1056/nejmoa0807646.", "ArticleIdList": ["10.1056/nejmoa0807646", "18997196"]}, {"Citation": "Qu D., Liu J., Lau C. W., Huang Y. IL-6 in diabetes and cardiovascular complications. British Journal of Pharmacology. 2014;171(15):3595\u20133603. doi: 10.1111/bph.12713.", "ArticleIdList": ["10.1111/bph.12713", "PMC4128059", "24697653"]}, {"Citation": "Lee J., Lee S., Zhang H., Hill M. A., Zhang C., Park Y. Interaction of IL-6 and TNF-\u03b1 contributes to endothelial dysfunction in type 2 diabetic mouse hearts. PLoS One. 2017;12(11) doi: 10.1371/journal.pone.0187189.e0187189", "ArticleIdList": ["10.1371/journal.pone.0187189", "PMC5667841", "29095915"]}, {"Citation": "Saba E., Jeong D., Irfan M., et al. Anti-inflammatory activity of Rg3-enriched Korean red ginseng extract in murine model of sepsis. Evidence-Based Complementary and Alternative Medicine. 2018;2018:11. doi: 10.1155/2018/6874692.6874692", "ArticleIdList": ["10.1155/2018/6874692", "PMC6201491", "30405742"]}, {"Citation": "Jeong D., Irfan M., Kim S.-D., et al. Ginsenoside Rg3-enriched red ginseng extract inhibits platelet activation and in vivo thrombus formation. Journal of Ginseng Research. 2017;41(4):548\u2013555. doi: 10.1016/j.jgr.2016.11.003.", "ArticleIdList": ["10.1016/j.jgr.2016.11.003", "PMC5628340", "29021703"]}, {"Citation": "El Haouari M., Rosado J. A. Phytochemical, anti-diabetic and cardiovascular properties of Urtica dioica L. (Urticaceae): a review. Mini Reviews in Medicinal Chemistry. 2019;19(1):63\u201371.", "ArticleIdList": ["30246639"]}, {"Citation": "Rahimi R., Nikfar S., Larijani B., Abdollahi M. A review on the role of antioxidants in the management of diabetes and its complications. Biomedicine & Pharmacotherapy. 2005;59(7):365\u2013373. doi: 10.1016/j.biopha.2005.07.002.", "ArticleIdList": ["10.1016/j.biopha.2005.07.002", "16081237"]}, {"Citation": "Robson R., Kundur A. R., Singh I. Oxidative stress biomarkers in type 2 diabetes mellitus for assessment of cardiovascular disease risk. Diabetes & Metabolic Syndrome: Clinical Research Reviews. 2018;12(3):455\u2013462. doi: 10.1016/j.dsx.2017.12.029.", "ArticleIdList": ["10.1016/j.dsx.2017.12.029", "29307576"]}, {"Citation": "Giacco F., Brownlee M. Oxidative stress and diabetic complications. Circulation Research. 2010;107(9):1058\u20131070. doi: 10.1161/circresaha.110.223545.", "ArticleIdList": ["10.1161/circresaha.110.223545", "PMC2996922", "21030723"]}, {"Citation": "Tsuzura S., Ikeda Y., Suehiro T., et al. Correlation of plasma oxidized low-density lipoprotein levels to vascular complications and human serum paraoxonase in patients with type 2 diabetes. Metabolism. 2004;53(3):297\u2013302. doi: 10.1016/j.metabol.2003.10.009.", "ArticleIdList": ["10.1016/j.metabol.2003.10.009", "15015140"]}, {"Citation": "Patra S. K., Singh K., Singh R. Paraoxonase 1: a better atherosclerotic risk predictor than HDL in type 2 diabetes mellitus. Diabetes & Metabolic Syndrome: Clinical Research Reviews. 2013;7(2):108\u2013111. doi: 10.1016/j.dsx.2013.02.007.", "ArticleIdList": ["10.1016/j.dsx.2013.02.007", "23680251"]}, {"Citation": "Lutchmansingh F. K., Hsu J. W., Bennett F. I., et al. Glutathione metabolism in type 2 diabetes and its relationship with microvascular complications and glycemia. PLoS One. 2018;13(6) doi: 10.1371/journal.pone.0198626.e0198626", "ArticleIdList": ["10.1371/journal.pone.0198626", "PMC5991679", "29879181"]}, {"Citation": "Zarfeshany A., Asgary S., Javanmard S. H. Potent health effects of pomegranate. Advanced Biomedical Research. 2014;3:p. 100. doi: 10.4103/2277-9175.129371.", "ArticleIdList": ["10.4103/2277-9175.129371", "PMC4007340", "24800189"]}, {"Citation": "Naseri R., Farzaei F., Haratipour P., et al. Anthocyanins in the management of metabolic syndrome: a pharmacological and biopharmaceutical review. Frontiers in Pharmacology. 2018;9:p. 1310. doi: 10.3389/fphar.2018.01310.", "ArticleIdList": ["10.3389/fphar.2018.01310", "PMC6288909", "30564116"]}, {"Citation": "Adler A. I., Stratton I. M., Neil H. A., et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study. BMJ. 2000;321(7258):412\u2013419. doi: 10.1136/bmj.321.7258.412.", "ArticleIdList": ["10.1136/bmj.321.7258.412", "PMC27455", "10938049"]}, {"Citation": "Hansson L., Zanchetti A., Carruthers S. G., et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the hypertension optimal treatment (HOT) randomised trial. The Lancet. 1998;351(9118):1755\u20131762. doi: 10.1016/s0140-6736(98)04311-6.", "ArticleIdList": ["10.1016/s0140-6736(98)04311-6", "9635947"]}, {"Citation": "Lastra G., Syed S., Kurukulasuriya L. R., Manrique C., Sowers J. R. Type 2 diabetes mellitus and hypertension. Endocrinology and Metabolism Clinics of North America. 2014;43(1):103\u2013122. doi: 10.1016/j.ecl.2013.09.005.", "ArticleIdList": ["10.1016/j.ecl.2013.09.005", "PMC3942662", "24582094"]}, {"Citation": "Yvan-Charvet L., Quignard-Boulang\u00e9 A. Role of adipose tissue renin-angiotensin system in metabolic and inflammatory diseases associated with obesity. Kidney International. 2011;79(2):162\u2013168. doi: 10.1038/ki.2010.391.", "ArticleIdList": ["10.1038/ki.2010.391", "20944545"]}, {"Citation": "Sen S., Chen S., Feng B., Wu Y., Lui E., Chakrabarti S. American ginseng (Panax quinquefolius) prevents glucose-induced oxidative stress and associated endothelial abnormalities. Phytomedicine. 2011;18(13):1110\u20131117. doi: 10.1016/j.phymed.2011.06.013.", "ArticleIdList": ["10.1016/j.phymed.2011.06.013", "21840692"]}, {"Citation": "Wu Q., Wang W., Li S., et al. American ginseng inhibits vascular smooth muscle cell proliferation via suppressing Jak/Stat pathway. Journal of Ethnopharmacology. 2012;144(3):782\u2013785. doi: 10.1016/j.jep.2012.09.046.", "ArticleIdList": ["10.1016/j.jep.2012.09.046", "PMC4109065", "23041701"]}, {"Citation": "Ma Y.-G., Liang L., Zhang Y.-B., et al. Berberine reduced blood pressure and improved vasodilation in diabetic rats. Journal of Molecular Endocrinology. 2017;59(3):191\u2013204. doi: 10.1530/jme-17-0014.", "ArticleIdList": ["10.1530/jme-17-0014", "28515053"]}, {"Citation": "Wang Y., Ding Y. Berberine protects vascular endothelial cells in hypertensive rats. International Journal of Clinical and Experimental Medicine. 2015;8(9):14896\u201314905.", "ArticleIdList": ["PMC4658860", "26628971"]}, {"Citation": "Kulkarni H., Mamtani M., Peralta J., et al. Soluble forms of intercellular and vascular cell adhesion molecules independently predict progression to type 2 diabetes in Mexican American families. PLoS One. 2016;11(3) doi: 10.1371/journal.pone.0151177.e0151177", "ArticleIdList": ["10.1371/journal.pone.0151177", "PMC4805238", "27007680"]}, {"Citation": "Meigs J. B., Hu F. B., Rifai N., Manson J. E. Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA. 2004;291(16):1978\u20131986. doi: 10.1001/jama.291.16.1978.", "ArticleIdList": ["10.1001/jama.291.16.1978", "15113816"]}, {"Citation": "Domingueti C. P., Dusse L. M. S. A., Carvalho M. d. G., de Sousa L. P., Gomes K. B., Fernandes A. P. Diabetes mellitus: the linkage between oxidative stress, inflammation, hypercoagulability and vascular complications. Journal of Diabetes and Its Complications. 2016;30(4):738\u2013745. doi: 10.1016/j.jdiacomp.2015.12.018.", "ArticleIdList": ["10.1016/j.jdiacomp.2015.12.018", "26781070"]}, {"Citation": "Campia U., Tesauro M., Di Daniele N., Cardillo C. The vascular endothelin system in obesity and type 2 diabetes: pathophysiology and therapeutic implications. Life Sciences. 2014;118(2):149\u2013155. doi: 10.1016/j.lfs.2014.02.028.", "ArticleIdList": ["10.1016/j.lfs.2014.02.028", "24607780"]}, {"Citation": "Li Z.-m., Xu S.-w., Liu P.-q. Salvia miltiorrhiza Burge (Danshen): a golden herbal medicine in cardiovascular therapeutics. Acta Pharmacologica Sinica. 2018;39(5):802\u2013824. doi: 10.1038/aps.2017.193.", "ArticleIdList": ["10.1038/aps.2017.193", "PMC5943903", "29698387"]}, {"Citation": "Ou H. C., Hsieh Y. L., Yang N. C., et al. Ginkgo biloba extract attenuates oxLDL-induced endothelial dysfunction via an AMPK-dependent mechanism. Journal of Applied Physiology. 2013;114(2):274\u2013285.", "ArticleIdList": ["23195633"]}, {"Citation": "Xing Z., Pei J., Huang J., Peng X., Chen P., Hu X. Relationship of obesity to adverse events among patients with mean 10-year history of type 2 diabetes mellitus: results of the ACCORD study. Journal of the American Heart Association. 2018;7(22) doi: 10.1161/JAHA.118.010512.e010512", "ArticleIdList": ["10.1161/JAHA.118.010512", "PMC6404442", "30554548"]}, {"Citation": "Kahn S. E., Hull R. L., Utzschneider K. M. Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature. 2006;444(7121):840\u2013846. doi: 10.1038/nature05482.", "ArticleIdList": ["10.1038/nature05482", "17167471"]}, {"Citation": "Wen X., Qian C., Zhang Y., et al. Key pathway and gene alterations in the gastric mucosa associated with obesity and obesity\u2010related diabetes. Journal of Cellular Biochemistry. 2018;120(4):6763\u20136771. doi: 10.1002/jcb.27976.", "ArticleIdList": ["10.1002/jcb.27976", "30450618"]}, {"Citation": "Hou X., Lu J., Weng J., et al. Impact of waist circumference and body mass index on risk of cardiometabolic disorder and cardiovascular disease in Chinese adults: a national diabetes and metabolic disorders survey. PLoS One. 2013;8(3) doi: 10.1371/journal.pone.0057319.e57319", "ArticleIdList": ["10.1371/journal.pone.0057319", "PMC3592870", "23520466"]}, {"Citation": "Siren R., Eriksson J. G., Vanhanen H. Waist circumference a good indicator of future risk for type 2 diabetes and cardiovascular disease. BMC Public Health. 2012;12(1):p. 631. doi: 10.1186/1471-2458-12-631.", "ArticleIdList": ["10.1186/1471-2458-12-631", "PMC3490795", "22877354"]}, {"Citation": "Koliaki C., Liatis S., Kokkinos A. Obesity and cardiovascular disease: revisiting an old relationship. Metabolism. 2019;92:98\u2013107. doi: 10.1016/j.metabol.2018.10.011.", "ArticleIdList": ["10.1016/j.metabol.2018.10.011", "30399375"]}, {"Citation": "Mudgil D., Barak S., Khatkar B. S. Guar gum: processing, properties and food applications\u2014a review. Journal of Food Science & Technology. 2014;51(3):409\u2013418. doi: 10.1007/s13197-011-0522-x.", "ArticleIdList": ["10.1007/s13197-011-0522-x", "PMC3931889", "24587515"]}, {"Citation": "Bahramsoltani R., Rahimi R., Farzaei M. H. Pharmacokinetic interactions of curcuminoids with conventional drugs: a review. Journal of Ethnopharmacology. 2017;209:1\u201312. doi: 10.1016/j.jep.2017.07.022.", "ArticleIdList": ["10.1016/j.jep.2017.07.022", "28734960"]}, {"Citation": "Soleymani S., Bahramsoltani R., Rahimi R., Abdollahi M. Clinical risks of St. John\u2019s Wort (Hypericum perforatum) co-administration. Expert Opinion on Drug Metabolism and Toxicology. 2017;13(10):1047\u20131062. doi: 10.1080/17425255.2017.1378342.", "ArticleIdList": ["10.1080/17425255.2017.1378342", "28885074"]}, {"Citation": "Izzo A. A., Di Carlo G., Borrelli F., Ernst E. Cardiovascular pharmacotherapy and herbal medicines: the risk of drug interaction. International Journal of Cardiology. 2005;98(1):1\u201314. doi: 10.1016/j.ijcard.2003.06.039.", "ArticleIdList": ["10.1016/j.ijcard.2003.06.039", "15676159"]}, {"Citation": "Izzo A. A. Interactions between herbs and conventional drugs: overview of the clinical data. Medical Principles and Practice. 2012;21(5):404\u2013428. doi: 10.1159/000334488.", "ArticleIdList": ["10.1159/000334488", "22236736"]}, {"Citation": "Maione F., Cicala C., Musciacco G., et al. Phenols, alkaloids and terpenes from medicinal plants with antihypertensive and vasorelaxant activities. A review of natural products as leads to potential therapeutic agents. Natural Product Communications. 2013;8(4):539\u2013544. doi: 10.1177/1934578x1300800434.", "ArticleIdList": ["10.1177/1934578x1300800434", "23738474"]}, {"Citation": "Menezes I. A., Barreto C. M., Antoniolli A. R., Santos M. R., de Sousa D. P. Hypotensive activity of terpenes found in essential oils. Zeitschrift fur Naturforschung. C, Journal of Biosciences. 2010;65(9-10):562\u2013566. doi: 10.1515/znc-2010-9-1005.", "ArticleIdList": ["10.1515/znc-2010-9-1005", "21138056"]}, {"Citation": "Rezaeiamiri E., Bahramsoltani R., Rahimi R. Plant-derived natural agents as dietary supplements for the regulation of glycosylated hemoglobin: a review of clinical trials. Clinical Nutrition. 2019;39(2):331\u2013342.", "ArticleIdList": ["30797623"]}, {"Citation": "Rohloff J., Dragland S., Mordal R., Iversen T.-H. Effect of harvest time and drying method on biomass production, essential oil yield, and quality of peppermint (Mentha piperita L.) Journal of Agricultural and Food Chemistry. 2005;53(10):4143\u20134148. doi: 10.1021/jf047998s.", "ArticleIdList": ["10.1021/jf047998s", "15884852"]}, {"Citation": "Tavarini S., Angelini L. G. Stevia rebaudiana Bertoni as a source of bioactive compounds: the effect of harvest time, experimental site and crop age on steviol glycoside content and antioxidant properties. Journal of the Science of Food and Agriculture. 2013;93(9):2121\u20132129. doi: 10.1002/jsfa.6016.", "ArticleIdList": ["10.1002/jsfa.6016", "23303701"]}], "ReferenceList": []}], "History": [{"Year": "2020", "Month": "11", "Day": "3"}, {"Year": "2021", "Month": "9", "Day": "1"}, {"Year": "2021", "Month": "9", "Day": "27", "Hour": "6", "Minute": "6"}, {"Year": "2021", "Month": "9", "Day": "28", "Hour": "6", "Minute": "0"}, {"Year": "2021", "Month": "9", "Day": "28", "Hour": "6", "Minute": "1"}, {"Year": "2021", "Month": "9", "Day": "16"}], "PublicationStatus": "epublish", "ArticleIdList": ["34567218", "PMC8460387", "10.1155/2021/6681540"]}}], "PubmedBookArticle": []}